- Home
- / Agios Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Agios Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$46.8
2024-10-29
Market Capitalization
$2.7 B
2024-10-29
Revenue
$26.8 M
FY, 2023
CreditSafe Score
?
Score changed on Dec 14, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.5M | 65.4M | 43.0M | 94.4M | 117.9M | 203.2M | 14.2M | 26.8M | |||
| Revenue growth, % | 155.8% | -9.5% | 18.2% | ||||||||
| Cost of goods sold | 1.4M | 1.3M | 2.8M | 1.7M | 2.9M | ||||||
| Gross profit | 93.0M | 116.6M | 200.4M | 12.5M | 23.9M | ||||||
| Gross profit margin, % | 98.5% | 98.9% | 98.6% | 88.0% | 89.3% | ||||||
| General and administrative expense | 9.9M | 19.1M | 36.0M | 50.7M | 71.1M | 114.1M | 132.0M | 149.1M | 121.4M | 121.7M | 119.9M |
| Operating expense total | 64.4M | 119.5M | 177.8M | 270.9M | 363.8M | 455.5M | 542.9M | 516.5M | 401.6M | 415.4M | |
| EBIT | (38.9M) | (54.1M) | (118.7M) | (201.0M) | (320.8M) | (362.5M) | (426.3M) | (316.1M) | (378.4M) | (389.0M) | (391.5M) |
| EBIT margin, % | -152.2% | -82.8% | -745.8% | -384.0% | -361.6% | -155.6% | -2732.1% | -1459.5% | |||
| Interest income | 55.0K | 203.0K | 968.0K | 2.5M | 6.1M | 16.5M | 14.9M | 6.6M | 836.0K | 12.8M | |
| Interest expense | 33.3M | ||||||||||
| Pre tax profit | (38.8M) | (53.9M) | (117.7M) | (198.5M) | (314.7M) | (346.0M) | (411.5M) | (327.4M) | (356.5M) | (231.8M) | (352.1M) |
| Income tax expense | 579.0K | (426.0K) | |||||||||
| Net Income | (39.4M) | (53.5M) | (117.7M) | (198.5M) | (314.7M) | (346.0M) | (411.5M) | (327.4M) | 1.6B | (231.8M) | (352.1M) |
| EPS | (4.2) | (6.3) |